Evexia Lifecare Ltd
Fundamental Score
Evexia Lifecare Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of EVEXIA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Interest Coverage (5.69x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
18 factors identified
Below-Average Return on Equity (0.32%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.30%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-15.09%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Premium Valuation Risk (P/E: 232.37x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-60.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Limited Growth History (1.97% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (-38.44% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-23.15% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Elevated Debt Levels (D/E: 2.16)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Low Promoter Commitment (3.36%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
Limited Institutional Interest (FII+DII: 0.56%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High Debt-to-Equity Ratio
Observation: Elevated financial risk due to high leverage.
Analysis: High debt levels may strain cash flows and increase financial risk during economic downturns.
Very High Debt Levels
Observation: Excessive leverage may strain cash flows.
Analysis: Debt-to-equity above 2.0 indicates potential financial distress risk.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Evexia Lifecare Ltd
About EVEXIA
Business Overview
Evexia Lifecare Limited, together with its subsidiaries, engages in trading of chemicals in India. The company trades in edible oils, diamonds, gold, and pharma chemicals products. It also offers plastic granules; lubricants; and website, mobile application, and software development services, as well as involved in manufacturing of eBikes. The company was formerly known as Kavit Industries Limited and changed its name to Evexia Lifecare Limited in January 2021. Evexia Lifecare Limited was incorporated in 1990 and is based in Vadodara, India.
Company Details
Key Leadership
Latest News
EVEXIA Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Evexia Lifecare Ltd (EVEXIA)?
As of 29 Jan 2026, 10:35 am IST, Evexia Lifecare Ltd (EVEXIA) is currently trading at ₹1.66. The stock has a market capitalization of ₹332.28 (Cr).
Is EVEXIA share price Overvalued or Undervalued?
EVEXIA is currently trading at a P/E ratio of 232.37x, compared to the industry average of 65.53x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Evexia Lifecare Ltd share price?
Key factors influencing EVEXIA's price include its quarterly earnings growth (Sales Growth: -3.67%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Evexia Lifecare Ltd a good stock for long-term investment?
Evexia Lifecare Ltd shows a 5-year Profit Growth of -23.15% and an ROE of 0.32%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 2.16 before investing.
How does Evexia Lifecare Ltd compare with its industry peers?
Evexia Lifecare Ltd competes with major peers in the Trading - Chemicals. Investors should compare EVEXIA's P/E of 232.37x and ROE of 0.32% against the industry averages to determine its competitive standing.
What is the P/E ratio of EVEXIA and what does it mean?
EVEXIA has a P/E ratio of 232.37x compared to the industry average of 65.53x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹232 for every ₹1 of annual earnings.
How is EVEXIA performing according to Bull Run's analysis?
EVEXIA has a Bull Run fundamental score of N/A/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does EVEXIA belong to?
EVEXIA operates in the Trading - Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Evexia Lifecare Ltd.
What is Return on Equity (ROE) and why is it important for EVEXIA?
EVEXIA has an ROE of 0.32%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Evexia Lifecare Ltd generates profits from shareholders' equity.
How is EVEXIA's debt-to-equity ratio and what does it indicate?
EVEXIA has a debt-to-equity ratio of 2.16, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is EVEXIA's dividend yield and is it a good dividend stock?
EVEXIA offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has EVEXIA grown over the past 5 years?
EVEXIA has achieved 5-year growth rates of: Sales Growth 1.97%, Profit Growth -23.15%, and EPS Growth -38.44%.
What is the promoter holding in EVEXIA and why does it matter?
Promoters hold 3.36% of EVEXIA shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is EVEXIA's market capitalization category?
EVEXIA has a market capitalization of ₹332 crores, placing it in the Small-cap category.
How volatile is EVEXIA stock?
EVEXIA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for EVEXIA?
EVEXIA has a 52-week high of ₹N/A and low of ₹N/A.
What is EVEXIA's operating profit margin trend?
EVEXIA has a 5-year average Operating Profit Margin (OPM) of -15.09%, indicating the company's operational efficiency.
How is EVEXIA's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -3.67% and YoY Profit Growth of -60.64%.
What is the institutional holding pattern in EVEXIA?
EVEXIA has FII holding of 0.47% and DII holding of 0.09%. Significant institutional holding often suggests professional confidence in the stock.